Why the study?
Is uncontrolled LDL-C associated with adverse outcomes in an older population following acute coronary syndrome?
Is uncontrolled LDL-C associated with adverse outcomes in an older population following acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
This study highlights the ongoing issue of low drug adherence in secondary prevention after ACS and reinforces the importance of LDL-C control to prevent adverse outcomes in older patients.
This observational long-term real-world study demonstrates low drug adherence and potential for improvement of risk factors after ACS. Furthermore, the study confirms that uncontrolled LDL-C is associated with adverse outcome even in this older population.
No takes yet. Share an insight, caveat, or question.
Bentzel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: